Abiopharma

🔍 GERO JAMES (Director)

Company: LCI INDUSTRIES (LCII)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | shares_owned_after: 319,486.00
• Acquired 234 shares of Deferred Stock Unit (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,871.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
• Holds 1,761 shares of Restricted Stock Unit (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 1,761.00 | Footnotes: F1, F4, F4, F5

Footnotes:

• F1: Each Stock Unit represents a contingent right to receive one share of LCII Common Stock.
• F2: These shares represent deferred stock units "DSUs" earned from quarterly director fees, the settlement of these DSUs will vest upon the conclusion of the director's board service with the Company per the election of the director.
• F3: Includes 109 stock unit(s) received as a result of regular cash dividends paid on reported payment date(s) March 27, 2026 to holders of registrant's common stock on the related reported record date(s). In accordance with the registrant's 2018 Omnibus Incentive Plan for underlying units granted under that plan, holders of stock units on the reported dividend record date(s) received additional dividend equivalent stock unit(s) subject to the same terms and conditions as the underlying stock units held on the reported record date(s).
• F4: These restricted stock units will vest in full on the earlier of May 15, 2026 or the date of the next year's annual meeting of stockholders.
• F5: Includes 16 stock unit(s) received as a result of regular cash dividends paid on reported payment date(s) March 27, 2026 to holders of registrant's common stock on the related reported record date(s). In accordance with the registrant's 2018 Omnibus Incentive Plan for underlying units granted under that plan, holders of stock units on the reported dividend record date(s) received additional dividend equivalent stock unit(s) subject to the same terms and conditions as the underlying stock units held on the reported record date(s).